You are here

Resource Center

AdvaMed Comments On Docket No. FDA-2017-D-5625-0002; Draft Guidance on Recommendations for Dual 510(k) and CLIA Waiver by Application Studies

Comments

application/pdf - 775.07 kB
Date:
03/30/2018
Issues: